学术探索
学术期刊
新闻热点
数据分析
智能评审

Antibiotics for secondary prevention of coronary artery disease: An ACES hypothesis but we need to PROVE IT

被引：18
作者：
Gelfand, EV
Cannon, CP
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA
来源：
AMERICAN HEART JOURNAL | 2004年 / 147卷 / 02期
关键词：
D O I：
10.1016/j.ahj.2003.09.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：202 / 209
页数：8
相关论文
共 67 条
[1]   Chlamydia pneumoniae inhibits apoptosis in human epithelial and monocyte cell lines [J].
Airenne, S ;
Surcel, HM ;
Tuukkanen, J ;
Leinonen, M ;
Saikku, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (04) :390-398
[2]   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study [J].
Anderson, JL ;
Muhlestein, JB ;
Carlquist, J ;
Allen, A ;
Trehan, S ;
Nielson, C ;
Hall, S ;
Brady, J ;
Egger, M ;
Horne, B ;
Lim, T .
CIRCULATION, 1999, 99 (12) :1540-1547
[3]   Association of serology with the endovascular presence of Chlamydia pneumoniae anti cytomegalovirus in coronary artery and vein graft disease [J].
Bartels, C ;
Maass, M ;
Bein, G ;
Brill, N ;
Bechtel, JFM ;
Leyh, R ;
Sieyers, HH .
CIRCULATION, 2000, 101 (02) :137-141
[4]   Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes [J].
Berger, M ;
Schröder, B ;
Daeschlein, G ;
Schneider, W ;
Busjahn, A ;
Buchwalow, I ;
Luft, FC ;
Haller, H .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 136 (03) :194-200
[5]   Chlamydia pneumoniae detection in atherosclerotic plaques in Italy [J].
Blasi, F ;
Fagetti, L ;
Allegra, L .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 :S444-S446
[6]   Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection [J].
Blasi, F ;
Boman, J ;
Esposito, G ;
Melissano, G ;
Chiesa, R ;
Cosentini, R ;
Tarsia, P ;
Tshomba, Y ;
Betti, M ;
Alessi, M ;
Morelli, N ;
Allegra, L .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :2074-2076
[7]   Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis:: Does study design influence results? [J].
Bloemenkamp, DGM ;
Mali, WPTM ;
Visseren, FLJ ;
van der Graaf, Y .
AMERICAN HEART JOURNAL, 2003, 145 (03) :409-417
[8]   Chlamydia pneumoniae and atherosclerosis:: Critical assessment of diagnostic methods and relevance to treatment studies [J].
Boman, J ;
Hammerschlag, MR .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (01) :1-+
[9]   Design of the Pravastatin or Atorvastation Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial [J].
Cannon, CP ;
McCabe, CH ;
Belder, R ;
Breen, J ;
Braunwald, E .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (07) :860-+
[10]   Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line [J].
Carratelli, CR ;
Rizzo, A ;
Catania, MR ;
Gallè, F ;
Losi, E ;
Hasty, DL ;
Rossano, F .
FEMS MICROBIOLOGY LETTERS, 2002, 215 (01) :69-74
1234567